Medium to long term health-related quality of life and treatment-related side-effects in patients treated with a single dose of adjuvant carboplatin for high-risk seminoma results from a pilot study
Authors
Cazzaniga, W; Pearce, A; Tanabalan, C; Rajan, P; Kinsella, N; Reid, A; Huddart, R; Nicol, DCollections
- Awaiting Allocation [239]